Medicine Creek Counseling | |
301 Nelson Street Cambridge NE 69022-3592 | |
(308) 737-3051 | |
Not Available |
Full Name | Medicine Creek Counseling |
---|---|
Speciality | Community/Behavioral Health |
Location | 301 Nelson Street, Cambridge, Nebraska |
Authorized Official Name and Position | Wendy Elizabeth Shifflet (LICENSED MENTAL HEALTH THERAPIST) |
Authorized Official Contact | 3087373051 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Medicine Creek Counseling Po Box 297 Cambridge NE 69022-0297 Ph: (308) 641-6387 | Medicine Creek Counseling 301 Nelson Street Cambridge NE 69022-3592 Ph: (308) 737-3051 |
NPI Number | 1114537529 |
---|---|
Provider Enumeration Date | 08/01/2020 |
Last Update Date | 02/21/2024 |
Certification Date | 02/19/2024 |
Medicare PECOS PAC ID | 4082039789 |
---|---|
Medicare Enrollment ID | O20200728003393 |
News Archive
NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.
Racial differences in parents' reports of concerns about their child's development to healthcare providers may contribute to delayed diagnosis of autism spectrum disorder (ASD) in black children, according to a study led by Georgia State University.
A team of researchers conducted a pilot study that enrolled families and undertook detailed clinical phenotyping of the proband to evaluate the effect of the whole genome sequencing approach on a genetic diagnosis of rare conditions by the NHS in the UK.
A state-of-the-art portable biosensing device based on micro- and nanotechnologies will empower doctors to rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.
Deft molecular detective work at Duke University Medical Center suggests that scientists may soon be able to resurrect niacin as one of the best and cheapest ways to manage cholesterol.
› Verified 2 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1114537529 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
Provider Name | Wendy E Shifflet |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1952878233 PECOS PAC ID: 6406277797 Enrollment ID: I20200521001668 |
News Archive
NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.
Racial differences in parents' reports of concerns about their child's development to healthcare providers may contribute to delayed diagnosis of autism spectrum disorder (ASD) in black children, according to a study led by Georgia State University.
A team of researchers conducted a pilot study that enrolled families and undertook detailed clinical phenotyping of the proband to evaluate the effect of the whole genome sequencing approach on a genetic diagnosis of rare conditions by the NHS in the UK.
A state-of-the-art portable biosensing device based on micro- and nanotechnologies will empower doctors to rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.
Deft molecular detective work at Duke University Medical Center suggests that scientists may soon be able to resurrect niacin as one of the best and cheapest ways to manage cholesterol.
› Verified 2 days ago
Provider Name | Sarah Sweeterman |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1265055636 PECOS PAC ID: 6901261411 Enrollment ID: I20230504002210 |
News Archive
NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.
Racial differences in parents' reports of concerns about their child's development to healthcare providers may contribute to delayed diagnosis of autism spectrum disorder (ASD) in black children, according to a study led by Georgia State University.
A team of researchers conducted a pilot study that enrolled families and undertook detailed clinical phenotyping of the proband to evaluate the effect of the whole genome sequencing approach on a genetic diagnosis of rare conditions by the NHS in the UK.
A state-of-the-art portable biosensing device based on micro- and nanotechnologies will empower doctors to rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.
Deft molecular detective work at Duke University Medical Center suggests that scientists may soon be able to resurrect niacin as one of the best and cheapest ways to manage cholesterol.
› Verified 2 days ago
News Archive
NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.
Racial differences in parents' reports of concerns about their child's development to healthcare providers may contribute to delayed diagnosis of autism spectrum disorder (ASD) in black children, according to a study led by Georgia State University.
A team of researchers conducted a pilot study that enrolled families and undertook detailed clinical phenotyping of the proband to evaluate the effect of the whole genome sequencing approach on a genetic diagnosis of rare conditions by the NHS in the UK.
A state-of-the-art portable biosensing device based on micro- and nanotechnologies will empower doctors to rapidly and accurately forewarn patients of their genetic risk of developing diseases such as cancer.
Deft molecular detective work at Duke University Medical Center suggests that scientists may soon be able to resurrect niacin as one of the best and cheapest ways to manage cholesterol.
› Verified 2 days ago